Antisense Therapy Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 RNA Antisense Therapy
1.2.3 DNA Antisense Therapy
1.3 Market by Application
1.3.1 Global Antisense Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antisense Therapy Market Perspective (2017-2028)
2.2 Antisense Therapy Growth Trends by Region
2.2.1 Antisense Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antisense Therapy Historic Market Size by Region (2017-2022)
2.2.3 Antisense Therapy Forecasted Market Size by Region (2023-2028)
2.3 Antisense Therapy Market Dynamics
2.3.1 Antisense Therapy Industry Trends
2.3.2 Antisense Therapy Market Drivers
2.3.3 Antisense Therapy Market Challenges
2.3.4 Antisense Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Therapy Players by Revenue
3.1.1 Global Top Antisense Therapy Players by Revenue (2017-2022)
3.1.2 Global Antisense Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Antisense Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense Therapy Revenue
3.4 Global Antisense Therapy Market Concentration Ratio
3.4.1 Global Antisense Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Therapy Revenue in 2021
3.5 Antisense Therapy Key Players Head office and Area Served
3.6 Key Players Antisense Therapy Product Solution and Service
3.7 Date of Enter into Antisense Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Therapy Breakdown Data by Type
4.1 Global Antisense Therapy Historic Market Size by Type (2017-2022)
4.2 Global Antisense Therapy Forecasted Market Size by Type (2023-2028)
5 Antisense Therapy Breakdown Data by Application
5.1 Global Antisense Therapy Historic Market Size by Application (2017-2022)
5.2 Global Antisense Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antisense Therapy Market Size (2017-2028)
6.2 North America Antisense Therapy Market Size by Type
6.2.1 North America Antisense Therapy Market Size by Type (2017-2022)
6.2.2 North America Antisense Therapy Market Size by Type (2023-2028)
6.2.3 North America Antisense Therapy Market Share by Type (2017-2028)
6.3 North America Antisense Therapy Market Size by Application
6.3.1 North America Antisense Therapy Market Size by Application (2017-2022)
6.3.2 North America Antisense Therapy Market Size by Application (2023-2028)
6.3.3 North America Antisense Therapy Market Share by Application (2017-2028)
6.4 North America Antisense Therapy Market Size by Country
6.4.1 North America Antisense Therapy Market Size by Country (2017-2022)
6.4.2 North America Antisense Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antisense Therapy Market Size (2017-2028)
7.2 Europe Antisense Therapy Market Size by Type
7.2.1 Europe Antisense Therapy Market Size by Type (2017-2022)
7.2.2 Europe Antisense Therapy Market Size by Type (2023-2028)
7.2.3 Europe Antisense Therapy Market Share by Type (2017-2028)
7.3 Europe Antisense Therapy Market Size by Application
7.3.1 Europe Antisense Therapy Market Size by Application (2017-2022)
7.3.2 Europe Antisense Therapy Market Size by Application (2023-2028)
7.3.3 Europe Antisense Therapy Market Share by Application (2017-2028)
7.4 Europe Antisense Therapy Market Size by Country
7.4.1 Europe Antisense Therapy Market Size by Country (2017-2022)
7.4.2 Europe Antisense Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Therapy Market Size (2017-2028)
8.2 Asia-Pacific Antisense Therapy Market Size by Type
8.2.1 Asia-Pacific Antisense Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antisense Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antisense Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Antisense Therapy Market Size by Application
8.3.1 Asia-Pacific Antisense Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antisense Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antisense Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Antisense Therapy Market Size by Region
8.4.1 Asia-Pacific Antisense Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antisense Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antisense Therapy Market Size (2017-2028)
9.2 Latin America Antisense Therapy Market Size by Type
9.2.1 Latin America Antisense Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Antisense Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Antisense Therapy Market Share by Type (2017-2028)
9.3 Latin America Antisense Therapy Market Size by Application
9.3.1 Latin America Antisense Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Antisense Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Antisense Therapy Market Share by Application (2017-2028)
9.4 Latin America Antisense Therapy Market Size by Country
9.4.1 Latin America Antisense Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Antisense Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Therapy Market Size (2017-2028)
10.2 Middle East & Africa Antisense Therapy Market Size by Type
10.2.1 Middle East & Africa Antisense Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antisense Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antisense Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Antisense Therapy Market Size by Application
10.3.1 Middle East & Africa Antisense Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antisense Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antisense Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Antisense Therapy Market Size by Country
10.4.1 Middle East & Africa Antisense Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antisense Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Antisense Therapy Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.1.5 Alnylam Pharmaceuticals Recent Developments
11.2 Ionis Pharmaceuticals, Inc.
11.2.1 Ionis Pharmaceuticals, Inc. Company Details
11.2.2 Ionis Pharmaceuticals, Inc. Business Overview
11.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Introduction
11.2.4 Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2017-2022)
11.2.5 Ionis Pharmaceuticals, Inc. Recent Developments
11.3 Arbutus Biopharma (Tekmira)
11.3.1 Arbutus Biopharma (Tekmira) Company Details
11.3.2 Arbutus Biopharma (Tekmira) Business Overview
11.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Introduction
11.3.4 Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2017-2022)
11.3.5 Arbutus Biopharma (Tekmira) Recent Developments
11.4 Isarna Therapeutics
11.4.1 Isarna Therapeutics Company Details
11.4.2 Isarna Therapeutics Business Overview
11.4.3 Isarna Therapeutics Antisense Therapy Introduction
11.4.4 Isarna Therapeutics Revenue in Antisense Therapy Business (2017-2022)
11.4.5 Isarna Therapeutics Recent Developments
11.5 Arrowhead
11.5.1 Arrowhead Company Details
11.5.2 Arrowhead Business Overview
11.5.3 Arrowhead Antisense Therapy Introduction
11.5.4 Arrowhead Revenue in Antisense Therapy Business (2017-2022)
11.5.5 Arrowhead Recent Developments
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Details
11.6.2 Dicerna Pharmaceuticals Business Overview
11.6.3 Dicerna Pharmaceuticals Antisense Therapy Introduction
11.6.4 Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.6.5 Dicerna Pharmaceuticals Recent Developments
11.7 Quark Pharmaceuticals
11.7.1 Quark Pharmaceuticals Company Details
11.7.2 Quark Pharmaceuticals Business Overview
11.7.3 Quark Pharmaceuticals Antisense Therapy Introduction
11.7.4 Quark Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.7.5 Quark Pharmaceuticals Recent Developments
11.8 Benitec Biopharma
11.8.1 Benitec Biopharma Company Details
11.8.2 Benitec Biopharma Business Overview
11.8.3 Benitec Biopharma Antisense Therapy Introduction
11.8.4 Benitec Biopharma Revenue in Antisense Therapy Business (2017-2022)
11.8.5 Benitec Biopharma Recent Developments
11.9 Sylentis
11.9.1 Sylentis Company Details
11.9.2 Sylentis Business Overview
11.9.3 Sylentis Antisense Therapy Introduction
11.9.4 Sylentis Revenue in Antisense Therapy Business (2017-2022)
11.9.5 Sylentis Recent Developments
11.10 Gradalis
11.10.1 Gradalis Company Details
11.10.2 Gradalis Business Overview
11.10.3 Gradalis Antisense Therapy Introduction
11.10.4 Gradalis Revenue in Antisense Therapy Business (2017-2022)
11.10.5 Gradalis Recent Developments
11.11 Sarepta Therapeutics
11.11.1 Sarepta Therapeutics Company Details
11.11.2 Sarepta Therapeutics Business Overview
11.11.3 Sarepta Therapeutics Antisense Therapy Introduction
11.11.4 Sarepta Therapeutics Revenue in Antisense Therapy Business (2017-2022)
11.11.5 Sarepta Therapeutics Recent Developments
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Antisense Therapy Introduction
11.12.4 Biogen Revenue in Antisense Therapy Business (2017-2022)
11.12.5 Biogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antisense Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of RNA Antisense Therapy
Table 3. Key Players of DNA Antisense Therapy
Table 4. Global Antisense Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Antisense Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Antisense Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Antisense Therapy Market Share by Region (2017-2022)
Table 8. Global Antisense Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Antisense Therapy Market Share by Region (2023-2028)
Table 10. Antisense Therapy Market Trends
Table 11. Antisense Therapy Market Drivers
Table 12. Antisense Therapy Market Challenges
Table 13. Antisense Therapy Market Restraints
Table 14. Global Antisense Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Antisense Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top Antisense Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2021)
Table 17. Ranking of Global Top Antisense Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Antisense Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antisense Therapy Product Solution and Service
Table 21. Date of Enter into Antisense Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Antisense Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Antisense Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Antisense Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Antisense Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Antisense Therapy Revenue Share by Application (2017-2022)
Table 29. Global Antisense Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Antisense Therapy Revenue Share by Application (2023-2028)
Table 31. North America Antisense Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Antisense Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Antisense Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Antisense Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Antisense Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Antisense Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Antisense Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Antisense Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Antisense Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Antisense Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Antisense Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Antisense Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Antisense Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Antisense Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Antisense Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Antisense Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Antisense Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Antisense Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Antisense Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Antisense Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Antisense Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Antisense Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Antisense Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Antisense Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Antisense Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Antisense Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Antisense Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Antisense Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Antisense Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Antisense Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Alnylam Pharmaceuticals Company Details
Table 62. Alnylam Pharmaceuticals Business Overview
Table 63. Alnylam Pharmaceuticals Antisense Therapy Product
Table 64. Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 65. Alnylam Pharmaceuticals Recent Developments
Table 66. Ionis Pharmaceuticals, Inc. Company Details
Table 67. Ionis Pharmaceuticals, Inc. Business Overview
Table 68. Ionis Pharmaceuticals, Inc. Antisense Therapy Product
Table 69. Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 70. Ionis Pharmaceuticals, Inc. Recent Developments
Table 71. Arbutus Biopharma (Tekmira) Company Details
Table 72. Arbutus Biopharma (Tekmira) Business Overview
Table 73. Arbutus Biopharma (Tekmira) Antisense Therapy Product
Table 74. Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 75. Arbutus Biopharma (Tekmira) Recent Developments
Table 76. Isarna Therapeutics Company Details
Table 77. Isarna Therapeutics Business Overview
Table 78. Isarna Therapeutics Antisense Therapy Product
Table 79. Isarna Therapeutics Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 80. Isarna Therapeutics Recent Developments
Table 81. Arrowhead Company Details
Table 82. Arrowhead Business Overview
Table 83. Arrowhead Antisense Therapy Product
Table 84. Arrowhead Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 85. Arrowhead Recent Developments
Table 86. Dicerna Pharmaceuticals Company Details
Table 87. Dicerna Pharmaceuticals Business Overview
Table 88. Dicerna Pharmaceuticals Antisense Therapy Product
Table 89. Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 90. Dicerna Pharmaceuticals Recent Developments
Table 91. Quark Pharmaceuticals Company Details
Table 92. Quark Pharmaceuticals Business Overview
Table 93. Quark Pharmaceuticals Antisense Therapy Product
Table 94. Quark Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 95. Quark Pharmaceuticals Recent Developments
Table 96. Benitec Biopharma Company Details
Table 97. Benitec Biopharma Business Overview
Table 98. Benitec Biopharma Antisense Therapy Product
Table 99. Benitec Biopharma Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 100. Benitec Biopharma Recent Developments
Table 101. Sylentis Company Details
Table 102. Sylentis Business Overview
Table 103. Sylentis Antisense Therapy Product
Table 104. Sylentis Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 105. Sylentis Recent Developments
Table 106. Gradalis Company Details
Table 107. Gradalis Business Overview
Table 108. Gradalis Antisense Therapy Product
Table 109. Gradalis Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 110. Gradalis Recent Developments
Table 111. Sarepta Therapeutics Company Details
Table 112. Sarepta Therapeutics Business Overview
Table 113. Sarepta Therapeutics Antisense Therapy Product
Table 114. Sarepta Therapeutics Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 115. Sarepta Therapeutics Recent Developments
Table 116. Biogen Company Details
Table 117. Biogen Business Overview
Table 118. Biogen Antisense Therapy Product
Table 119. Biogen Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 120. Biogen Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense Therapy Market Share by Type: 2021 VS 2028
Figure 2. RNA Antisense Therapy Features
Figure 3. DNA Antisense Therapy Features
Figure 4. Global Antisense Therapy Market Share by Application: 2021 VS 2028
Figure 5. Cancer Case Studies
Figure 6. Cardiovascular Case Studies
Figure 7. HBV Case Studies
Figure 8. Other Case Studies
Figure 9. Antisense Therapy Report Years Considered
Figure 10. Global Antisense Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Antisense Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Antisense Therapy Market Share by Region: 2021 VS 2028
Figure 13. Global Antisense Therapy Market Share by Players in 2021
Figure 14. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Antisense Therapy Revenue in 2021
Figure 16. North America Antisense Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Antisense Therapy Market Size Market Share by Type (2017-2028)
Figure 18. North America Antisense Therapy Market Size Market Share by Application (2017-2028)
Figure 19. North America Antisense Therapy Market Size Share by Country (2017-2028)
Figure 20. United States Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Antisense Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Antisense Therapy Market Size Market Share by Type (2017-2028)
Figure 24. Europe Antisense Therapy Market Size Market Share by Application (2017-2028)
Figure 25. Europe Antisense Therapy Market Size Share by Country (2017-2028)
Figure 26. Germany Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Antisense Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Antisense Therapy Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Antisense Therapy Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Antisense Therapy Market Size Share by Region (2017-2028)
Figure 36. China Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Antisense Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Antisense Therapy Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Antisense Therapy Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Antisense Therapy Market Size Share by Country (2017-2028)
Figure 46. Mexico Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Antisense Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Antisense Therapy Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Antisense Therapy Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Antisense Therapy Market Size Share by Country (2017-2028)
Figure 52. Turkey Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 56. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 57. Arbutus Biopharma (Tekmira) Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 58. Isarna Therapeutics Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 59. Arrowhead Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 60. Dicerna Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 61. Quark Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 62. Benitec Biopharma Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 63. Sylentis Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 64. Gradalis Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 65. Sarepta Therapeutics Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 66. Biogen Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Industry Market Size
